GLP-1 Podcast with Flow Wellness Medical Director Key takeaways from the GLP-1 podcast GLP-1 medications were first developed for diabetes, then became widely used for weight loss after weekly dosing became available
As the gut adjusts, symptoms typically resolve
Recent systemic review and meta-analysis demonstrated, that treatment with functional agonists of GLP-1 which included both GLP-1RAs and DPP4 inhibitors resulted in a significant reduction of depression rating scores and tended to be superior over control treatments, which supports the hypothesis of their antidepressant action in humans
Constipation becomes a real issue, and if fiber intake drops alongside appetite, it compounds the problem significantly
Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
A single early dose does not accelerate weight loss or improve blood sugar control